Form D/A CTLD Growth & Income
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 424B5 NANOVIRICIDES, INC.
PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5) (To Prospectus dated June 15, 2026) Registration No. 333-296550
NanoViricides, Inc.
2,416,339 Shares of Common Stock
Pre-Funded Warrants to Purchase Up to 100,000 Shares of Common Stock
100,000 Shares of Common Stock Underlying Such Pre-Funded Warrants
Common Stock Warrants to Purchase Up to 2,516,339 Shares of Common Stock
Pursuant to this... (continue reading...)
Form 6-K Perfect Corp. For: Jul 27
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934For the month of July, 2026Commission File Number: 001-41540 Perfect Corp. 14F, No. 98 Minquan RoadXindian DistrictNew Taipei City 231Taiwan(Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or... (continue reading...)
Form 6-K PRUDENTIAL PLC For: Jul 27
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the
month of July, 2026
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
13/F, One International Finance Centre,
1 Harbour View Street, Central,
Hong Kong, China
(Address
of principal executive... (continue reading...)
More SEC Filings
View Older Stories-
Form N-PX IvyRock Asset Management For: Jun 30
-
Form SC14D9C Forte Biosciences, Inc. Filed by: Forte Biosciences, Inc.
-
Form SC14D9C Forte Biosciences, Inc. Filed by: Forte Biosciences, Inc.
-
Form 10-Q Clean Energy Technologie For: Mar 31
-
Form 4 Greenwich LifeSciences, For: Jul 23 Filed by: Patel Snehal
-
Form D SUMITOMO MITSUI FINANCIA
-
Form S-4/A ONE Nuclear Energy LLC Filed by: Hennessy Capital Investment Corp. VII
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 6-K Sanofi For: Jul 27
-
Form S-4/A NON INVASIVE MONITORING
-
Form 8-K Profusa, Inc. For: Jul 27
-
Form 6-K The9 LTD For: Jul 27
-
Form 8-K ENSIGN GROUP, INC For: Jul 27
-
Form 8-K Baker Hughes Co For: Jul 26
-
Form 4 36Kr Holdings Inc. For: Jul 01 Filed by: Feng Dagang
-
Form 6-K ICICI BANK LTD For: Jul 24
-
Form 6-K ERICSSON LM TELEPHONE For: Jul 27
-
Form 13F-HR Shengqi Capital (Hong For: Jun 30
-
Form 6-K Radiopharm Theranostics For: Jul 27
-
Form 8-K Forte Biosciences, Inc. For: Jul 26
-
Form 424B5 NANOVIRICIDES, INC.
-
Form 6-K Li Auto Inc. For: Jul 27
-
Form DEFA14A FLEX LTD.
-
Form 6-K Lufax Holding Ltd For: Jul 27
-
Form 424B5 Radiopharm Theranostics
-
Form 10-Q ENSIGN GROUP, INC For: Jun 30
-
Form 6-K HDFC BANK LTD For: Jul 24
-
Form 8-K Antero Midstream Corp For: Jul 24
-
Form 6-K ARGENX SE For: Jul 27
-
Form 424B3 REPUBLIC OF CHILE
-
Form EFFECT Bone Biologics Corp
-
Form DEFA14A SOUTHERN CALIFORNIA GAS
-
Form 8-K Artificial Intelligence For: Jul 27
-
Form 6-K Zhihu Inc. For: Jul 27
-
Form 8-K International Media Acqu For: Jul 24
-
Form 6-K Trip.com Group Ltd For: Jul 27
-
Form 8-K SemiLEDs Corp For: Jul 27
-
Form 6-K Veraxa Biotech Holding For: Jul 27
-
Form EFFECT Artificial Intelligence
-
Form 6-K Legend Biotech Corp For: Jul 27
-
Form EFFECT Brenmiller Energy Ltd.
-
Form EFFECT Jaguar Health, Inc.
-
Form EFFECT HNO International, Inc.
-
Form EFFECT Jaguar Health, Inc.
-
Form EFFECT Leef Brands Inc.
-
Form EFFECT United Maritime Corp
-
Form EFFECT ACCENDRA HEALTH INC/VA/
-
Form EFFECT QUANTUM CORP /DE/
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
